홈 > 시장보고서 > 의료기기 > 환자 모니터링

시장보고서

상품코드

1688905

세계의 ECG 장치 시장 규모와 예측(2021-2031년) - 지역별 점유율, 동향, 성장 기회 분석 보고서 : 제품별, 리드 유형별, 기술별, 최종 사용자별, 지역별

ECG Devices Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Lead Type, Technology, End User, and Geography

발행일: 2025년 03월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 188 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 ECG 장치 시장 규모는 2024년 33억 1,000만 달러에서 성장해, 2031년에는 45억 달러에 이를 것으로 예측되고 있으며, 2025-2031년 CAGR 4.5%로 예측되고 있습니다. ECG 장치 시장의 성장은 심혈관 장애 유병률 증가, 정부 이니셔티브 및 건강 관리 투자의 급증으로 인한 것입니다.

ECG 장치는 심장의 전기적 활동을 측정하는 데 사용되는 의료기기입니다. 이 장비는 부정맥, 심장 마비 및 기타 심장 이상을 포함한 심장 질환의 진단에 매우 중요합니다. 각 심박의 트리거가 되는 전기 신호를 감지하여 심장 리듬과 전반적인 건강 상태에 대한 중요한 정보를 제공할 수 있습니다.

북미의 ECG 장치 시장은 미국, 캐나다, 멕시코로 구분됩니다. 북미는 시장 성장을 견인하는 매우 중요한 역할을 할 것으로 예상됩니다. 이 성장의 주요 발전 요인으로는 심혈관 질환의 이환율 증가, 예방 건강 관리에 대한 관심 증가, 정비 된 건강 관리 인프라의 존재 등이 있습니다. 또한 정부의 지원, 노화, 심장 관련 질환에 대한 의식이 높아지면서 이 지역의 ECG 장치 시장의 확대를 더욱 강화하고 있습니다. 기술의 발전도 중요한 역할을 합니다. 디지털 ECG 장치의 기술 혁신은 정확성, 휴대성 및 사용 편의성을 향상시키고 의료 서비스 제공업체와 환자 모두에게 더욱 친숙하고 효과적입니다.

북미에서는 미국이 ECG 장치 시장에서 큰 점유율을 차지하고 있습니다. 미국에서는 노인 인구 증가, 심혈관 질환 유병률 및 인지도 향상, 예방 의학에 대한 주목 받기, 중요한 심장 지표를 모니터링하는 기술의 진보, 원격 모니터링 추진 등의 요인으로 ECG 장치에 대한 수요가 특히 높아지고 있습니다. 미국 질병예방관리센터(CDC)에 따르면 국내에서는 매년 80만 5,000명이 심장 발작을 경험하고 있으며, 그 중 60만 5,000명이 최초의 심장 발작입니다. Million Hearts 2021의 데이터에 따르면 미국에서는 연간 150만 명의 심근경색과 뇌졸중이 발생하고 있습니다. 미국에서 가장 많은 심장병은 관상 동맥 질환(CAD)입니다. CDC 2022년 추계에 따르면 미국 성인 2,010만 명이 CAD를 보고하고 있습니다. 부정맥, 심근경색, 심부전 등 다양한 심장 질환의 진단 및 모니터링에 필수적인 ECG 장치는 CVD의 조기 발견, 치료 계획, 장기 관리에 중요한 역할을 합니다.

미국 심장협회에 따르면 미국에서는 성인의 절반 가까이가 일부 CVD를 앓고 있습니다. 2035년까지 1억 3,000만 명 이상의 성인, 즉 미국 인구의 45.1%가 일부 CVD를 호소할 것으로 예상됩니다. 이러한 장치는 비침습적이고 신속하며, 보다 진보된 영상 진단 및 의료 개입의 필요성과 같은 추가 관리를 안내하는 단서를 제공합니다.

CVD의 조기 발견을 촉진하는 공중보건 활동과 계몽 캠페인은 ECG 장치의 채용을 늘리고 공중보건의 전반적인 성과를 향상시키는 데 있어 매우 중요한 역할을 하고 있습니다. 예를 들어, 심장병 및 뇌졸중과 관련된 위험 인자를 예방, 관리 및 감소시키기 위해 CDC의 심장병 및 뇌졸중 예방 부문(DHDSP)은 주, 지방 및 부족 사람들의 병리 관리를 지원합니다. DHDSP와 함께 당뇨병 번역 부문은 심장병과 뇌졸중 등 건강 문제를 해결하기 위해 50개 주와 콜롬비아 특별구를 지원하고 있습니다. 시장 개척을 위해 시장 진출기업은 유기적 및 무기적 전략도 채용하고 있습니다.

지속적인 기술 발전과 지속적인 건강 모니터링에 대한 수요가 증가함에 따라 스마트 ECG 웨어러블 장치에 대한 길을 열고 있습니다. 스마트 ECG 웨어러블 장치에 대한 동향 증가는 주로 심장의 건강 상태를 라이브로 모니터링하는 ECG 센서와 통합된 스마트 워치와 피트니스 트래커의 수용이 확대되고 있기 때문입니다. 예를 들어, Apple Watch Series 4 이상 버전에는 심방세동(AFib) 및 기타 심장 질환을 감지하는 데 도움이 되는 FDA 승인 ECG 앱이 포함되어 있습니다. 마찬가지로 Fitbit Sense 스마트 워치에 장착된 ECG 기능을 통해 사용자는 부정맥을 감지할 수 있습니다. ECG 기술을 웨어러블 기기에 통합함으로써 기존의 ECG 검사와 달리 심장 건강 상태를 지속적으로 모니터링할 수 있습니다. 장기적인 모니터링에 대한 급격한 기울기는 심장 이상의 조기 발견을 가능하게 하여 병원 진찰과 건강 관리 지출을 줄일 수 있습니다. JAMA Cardiology의 보고서에 따르면, 웨어러블 ECG 모니터를 통한 심장 질환의 검출은 환자의 예후를 개선하고 사망률을 감소시키는데 도움이 되는 것으로 밝혀졌습니다. 게다가 인공지능(AI)의 발전은 주요 기술의 발전과 함께 스마트 ECG 웨어러블 장치에 대한 수요를 창출할 것으로 예상됩니다. 인공지능 기반 알고리즘은 ECG 데이터를 실시간으로 분석하고 심각한 문제로 발전하기 훨씬 전에 심장 문제에 대한 예측 통찰력을 제공합니다. 정밀도 향상, 비용 절감, 웨어러블 ECG와 원격 의료 플랫폼의 통합은 개인화된 심장혈관 관리의 시대를 초래하여 ECG 장치의 향후 시장 성장에 기여합니다.

이 보고서는 세계 ECG 장치 시장을 조사했으며, 시장 개요와 함께 제품별, 리드 유형별, 기술별, 최종 사용자별, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.

GE HealthCare Technologies Inc
Spacelabs Healthcare
Nihon Kohden Corp
Schiller AG
Hill-Rom Holdings Inc
BPL Medical Technologies Pvt Ltd
Koninklijke Philips NV
AliveCor, Inc
FUKUDA DENSHI
EB Neuro SPA
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Viatom Technology Co., Ltd.
CompuMed Inc.
Norav Medical
custo med GmbH

제14장 부록

JHS 25.04.03

The ECG Devices market is anticipated to grow from US$ 3.31 billion in 2024 and is projected to reach US$ 4.50 billion by 2031; it is expected to register a CAGR of 4.5% during 2025-2031. The ECG devices market growth is attributed to the increasing prevalence of cardiovascular disorders and a surge in government initiatives and healthcare investment.

ECG devices are medical instruments used to measure the electrical activity of the heart. These devices are crucial for diagnosing heart conditions, including arrhythmia, heart attacks, and other cardiac abnormalities. They detect the electrical signals that trigger each heartbeat and can provide vital information about the heart's rhythm and overall health.

The ECG devices market in North America is segmented into the US, Canada, and Mexico. The North American region is anticipated to play a pivotal role in driving the market's growth. Key factors contributing to this growth include the increasing incidence of cardiovascular disease, an increased focus on preventive healthcare, and the presence of well-developed healthcare infrastructure. Additionally, government support, an aging population, and growing awareness of heart-related diseases are further propelling the expansion of the ECG devices market in the region. Technological advancements have also played a crucial role. Innovations in digital ECG devices have enhanced accuracy, portability, and user-friendliness, making them more accessible and effective for both healthcare providers and patients.

In North America, the US holds a significant share of the ECG devices market. In the US, the demand for ECG devices has been particularly strong due to factors such as the rising geriatric population, growing prevalence and awareness of cardiovascular diseases, increasing focus on preventive healthcare, technological advancements in monitoring vital cardiac indicators, and the push for remote monitoring. According to the Centers for Disease Control and Prevention (CDC), ~805,000 people experience a heart attack in the country every year, of which ~605,000 individuals are first-time heart attacks. As per the Million Hearts 2021 data, ~1.5 million myocardial infarctions and strokes occur in the US annually. The most common type of heart disease in the nation is coronary artery disease (CAD). Per the CDC 2022 estimates, 20.1 million US adults report CAD. ECG devices, which are critical in diagnosing and monitoring various heart conditions such as arrhythmia, heart attack, and heart failure, play a vital role in early detection, treatment planning, and long-term management of CVD.

According to the American Heart Association, nearly half of adults in the US have some type of CVD, and it is estimated that the number of adults suffering from heart failure is projected to increase by 2035 by 40%. By 2035, over 130 million adults, i.e., 45.1% of the US population, are expected to report some form of CVD. These devices are noninvasive, quick, and provide clues to guide further management, such as the need for more advanced imaging or medical interventions.

Public health initiatives and awareness campaigns promoting early detection of CVDs have played a pivotal role in increasing the adoption of ECG devices and improving overall public health outcomes. For instance, to prevent, manage, and reduce the risk factors associated with heart disease and stroke, the CDC's Division for Heart Disease and Stroke Prevention (DHDSP) supports state, local, and tribal populations in managing the condition. Along with DHDSP, the Division of Diabetes Translation also supports all 50 states and the District of Columbia to address health problems such as heart disease and stroke. Market players are also adopting organic and inorganic strategies for market development. For instance, in December 2024, HeartBeam, Inc., a pioneering medical technology company dedicated to revolutionizing cardiac care through advanced insights, announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the HeartBeam system, specifically for comprehensive arrhythmia assessment. This device, distinguished by its patented design, is the first of its kind to achieve FDA approval. As a high-fidelity ECG system featuring a compact, credit card-sized form and a cable-free design, it effectively captures heart signals from three different angles, providing crucial information for actionable heart health management. Such advancements in ECG devices are promoting its market in the US.

Technological Advancement and Development of Smart Wearables to Provide Market Opportunities in Future

Continuous technological advancement and increasing demand for continuous health monitoring have paved the way for smart ECG wearable devices. The increasing trend toward smart ECG wearable devices is driven mainly by the growing acceptance of smartwatches and fitness trackers integrated with ECG sensors for live heart health monitoring. For instance, Apple Watch Series 4 and later versions have an FDA-approved ECG app which helps in the detection of atrial fibrillation (AFib) and other heart conditions. Similarly, ECG functionality in the Fitbit Sense smartwatch allows users to detect irregular heart rhythms. The integration of ECG technology into wearable devices allows for continuous heart health monitoring, contrary to traditional ECG testing. The surging inclination toward long-term monitoring would allow for the early detection of heart abnormalities, possibly reducing hospital visits and healthcare expenditure. As per the JAMA Cardiology report, the detection of heart conditions via wearable ECG monitors was found to be beneficial in improving the outcome of patients and reducing mortality. Furthermore, the advancement in artificial intelligence (AI), along with key technological progress, is expected to create demand for smart ECG wearable devices. Algorithms based on artificial intelligence will analyze ECG data in real-time to provide predictive insights into problems with the heart long before it can become a significant issue. The increasing accuracy, decreasing costs, and integration of wearable ECG with telehealth platforms will lead to the era of personalized cardiovascular care, contributing to ECG devices' market growth in the coming years.

The US Food and Drug Administration, American College Cardiology, The Barcelona Institute for Global Health, and Our World in data are among the primary and secondary sources referred to while preparing the ECG devices market report.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. ECG Devices Market Landscape

4.1 Overview
4.2 PEST Analysis

5. ECG Devices Market - Key Market Dynamics

5.1 ECG Devices Market - Key Market Dynamics
5.2 Market Drivers:
- 5.2.1 Increasing Incidences of Cardiovascular Diseases
- 5.2.2 Government Initiatives and Healthcare Investments
5.3 Market Restraints
- 5.3.1 Stringent Regulatory Requirements and Technical Issues
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
- 5.5.1 Technological Advancement and Development of Smart Wearables
5.6 Impact of Drivers and Restraints:

6. ECG Devices Market - Global Market Analysis

6.1 ECG Devices Market Revenue (US$ Million), 2021-2031
6.2 ECG Devices Market Forecast Analysis

7. ECG Devices Market Analysis - by Product

7.1 Resting ECG
- 7.1.1 Overview
- 7.1.2 Resting ECG: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Stress ECG
- 7.2.1 Overview
- 7.2.2 Stress ECG: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)

8. ECG Devices Market Analysis - by Lead Type

8.1-Lead ECG
- 8.1.1 Overview
- 8.1.2-Lead ECG: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.2 3-6 Lead ECG
- 8.2.1 Overview
- 8.2.2 3-6 Lead ECG: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Single Lead
- 8.3.1 Overview
- 8.3.2 Single Lead: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)

9. ECG Devices Market Analysis - by Technology

9.1 Portable (Wired) ECG System
- 9.1.1 Overview
- 9.1.2 Portable (Wired) ECG System: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Wireless ECG System
- 9.2.1 Overview
- 9.2.2 Wireless ECG System: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)

10. ECG Devices Market Analysis - by End User

10.1 Hospital and Clinics
- 10.1.1 Overview
- 10.1.2 Hospital and Clinics: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Ambulatory Surgical Centers
- 10.2.1 Overview
- 10.2.2 Ambulatory Surgical Centers: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Cardiac Centers
- 10.3.1 Overview
- 10.3.2 Cardiac Centers: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Others
- 10.4.1 Overview
- 10.4.2 Others: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)

11. ECG Devices Market - Geographical Analysis

11.1 North America
- 11.1.1 North America ECG Devices Market Overview
- 11.1.2 North America: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
  - 11.1.2.1 North America: ECG Devices Market - Revenue and Forecast Analysis - by Product
  - 11.1.2.2 North America: ECG Devices Market - Revenue and Forecast Analysis - by Lead Type
  - 11.1.2.3 North America: ECG Devices Market - Revenue and Forecast Analysis - by Technology
  - 11.1.2.4 North America: ECG Devices Market - Revenue and Forecast Analysis - by End User
- 11.1.3 North America: ECG Devices Market - Revenue and Forecast Analysis - by Country
  - 11.1.3.1 United States: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.1.3.1.1 United States: ECG Devices Market Breakdown, by Product
    - 11.1.3.1.2 United States: ECG Devices Market Breakdown, by Lead Type
    - 11.1.3.1.3 United States: ECG Devices Market Breakdown, by Technology
    - 11.1.3.1.4 United States: ECG Devices Market Breakdown, by End User
  - 11.1.3.2 Canada: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.1.3.2.1 Canada: ECG Devices Market Breakdown, by Product
    - 11.1.3.2.2 Canada: ECG Devices Market Breakdown, by Lead Type
    - 11.1.3.2.3 Canada: ECG Devices Market Breakdown, by Technology
    - 11.1.3.2.4 Canada: ECG Devices Market Breakdown, by End User
  - 11.1.3.3 Mexico: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.1.3.3.1 Mexico: ECG Devices Market Breakdown, by Product
    - 11.1.3.3.2 Mexico: ECG Devices Market Breakdown, by Lead Type
    - 11.1.3.3.3 Mexico: ECG Devices Market Breakdown, by Technology
    - 11.1.3.3.4 Mexico: ECG Devices Market Breakdown, by End User
11.2 Europe
- 11.2.1 Europe ECG Devices Market Overview
- 11.2.2 Europe: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
  - 11.2.2.1 Europe: ECG Devices Market - Revenue and Forecast Analysis - by Product
  - 11.2.2.2 Europe: ECG Devices Market - Revenue and Forecast Analysis - by Lead Type
  - 11.2.2.3 Europe: ECG Devices Market - Revenue and Forecast Analysis - by Technology
  - 11.2.2.4 Europe: ECG Devices Market - Revenue and Forecast Analysis - by End User
- 11.2.3 Europe: ECG Devices Market - Revenue and Forecast Analysis - by Country
  - 11.2.3.1 Germany: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.3.1.1 Germany: ECG Devices Market Breakdown, by Product
    - 11.2.3.1.2 Germany: ECG Devices Market Breakdown, by Lead Type
    - 11.2.3.1.3 Germany: ECG Devices Market Breakdown, by Technology
    - 11.2.3.1.4 Germany: ECG Devices Market Breakdown, by End User
  - 11.2.3.2 United Kingdom: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.3.2.1 United Kingdom: ECG Devices Market Breakdown, by Product
    - 11.2.3.2.2 United Kingdom: ECG Devices Market Breakdown, by Lead Type
    - 11.2.3.2.3 United Kingdom: ECG Devices Market Breakdown, by Technology
    - 11.2.3.2.4 United Kingdom: ECG Devices Market Breakdown, by End User
  - 11.2.3.3 France: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.3.3.1 France: ECG Devices Market Breakdown, by Product
    - 11.2.3.3.2 France: ECG Devices Market Breakdown, by Lead Type
    - 11.2.3.3.3 France: ECG Devices Market Breakdown, by Technology
    - 11.2.3.3.4 France: ECG Devices Market Breakdown, by End User
  - 11.2.3.4 Italy: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.3.4.1 Italy: ECG Devices Market Breakdown, by Product
    - 11.2.3.4.2 Italy: ECG Devices Market Breakdown, by Lead Type
    - 11.2.3.4.3 Italy: ECG Devices Market Breakdown, by Technology
    - 11.2.3.4.4 Italy: ECG Devices Market Breakdown, by End User
  - 11.2.3.5 Spain: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.3.5.1 Spain: ECG Devices Market Breakdown, by Product
    - 11.2.3.5.2 Spain: ECG Devices Market Breakdown, by Lead Type
    - 11.2.3.5.3 Spain: ECG Devices Market Breakdown, by Technology
    - 11.2.3.5.4 Spain: ECG Devices Market Breakdown, by End User
  - 11.2.3.6 Rest of Europe: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.3.6.1 Rest of Europe: ECG Devices Market Breakdown, by Product
    - 11.2.3.6.2 Rest of Europe: ECG Devices Market Breakdown, by Lead Type
    - 11.2.3.6.3 Rest of Europe: ECG Devices Market Breakdown, by Technology
    - 11.2.3.6.4 Rest of Europe: ECG Devices Market Breakdown, by End User
11.3 Asia Pacific
- 11.3.1 Asia Pacific ECG Devices Market Overview
- 11.3.2 Asia Pacific: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
  - 11.3.2.1 Asia Pacific: ECG Devices Market - Revenue and Forecast Analysis - by Product
  - 11.3.2.2 Asia Pacific: ECG Devices Market - Revenue and Forecast Analysis - by Lead Type
  - 11.3.2.3 Asia Pacific: ECG Devices Market - Revenue and Forecast Analysis - by Technology
  - 11.3.2.4 Asia Pacific: ECG Devices Market - Revenue and Forecast Analysis - by End User
- 11.3.3 Asia Pacific: ECG Devices Market - Revenue and Forecast Analysis - by Country
  - 11.3.3.1 China: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.1.1 China: ECG Devices Market Breakdown, by Product
    - 11.3.3.1.2 China: ECG Devices Market Breakdown, by Lead Type
    - 11.3.3.1.3 China: ECG Devices Market Breakdown, by Technology
    - 11.3.3.1.4 China: ECG Devices Market Breakdown, by End User
  - 11.3.3.2 Japan: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.2.1 Japan: ECG Devices Market Breakdown, by Product
    - 11.3.3.2.2 Japan: ECG Devices Market Breakdown, by Lead Type
    - 11.3.3.2.3 Japan: ECG Devices Market Breakdown, by Technology
    - 11.3.3.2.4 Japan: ECG Devices Market Breakdown, by End User
  - 11.3.3.3 India: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.3.1 India: ECG Devices Market Breakdown, by Product
    - 11.3.3.3.2 India: ECG Devices Market Breakdown, by Lead Type
    - 11.3.3.3.3 India: ECG Devices Market Breakdown, by Technology
    - 11.3.3.3.4 India: ECG Devices Market Breakdown, by End User
  - 11.3.3.4 Australia: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.4.1 Australia: ECG Devices Market Breakdown, by Product
    - 11.3.3.4.2 Australia: ECG Devices Market Breakdown, by Lead Type
    - 11.3.3.4.3 Australia: ECG Devices Market Breakdown, by Technology
    - 11.3.3.4.4 Australia: ECG Devices Market Breakdown, by End User
  - 11.3.3.5 South Korea: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.5.1 South Korea: ECG Devices Market Breakdown, by Product
    - 11.3.3.5.2 South Korea: ECG Devices Market Breakdown, by Lead Type
    - 11.3.3.5.3 South Korea: ECG Devices Market Breakdown, by Technology
    - 11.3.3.5.4 South Korea: ECG Devices Market Breakdown, by End User
  - 11.3.3.6 Rest of APAC: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.6.1 Rest of APAC: ECG Devices Market Breakdown, by Product
    - 11.3.3.6.2 Rest of APAC: ECG Devices Market Breakdown, by Lead Type
    - 11.3.3.6.3 Rest of APAC: ECG Devices Market Breakdown, by Technology
    - 11.3.3.6.4 Rest of APAC: ECG Devices Market Breakdown, by End User
11.4 Middle East and Africa
- 11.4.1 Middle East and Africa ECG Devices Market Overview
- 11.4.2 Middle East and Africa: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
  - 11.4.2.1 Middle East and Africa: ECG Devices Market - Revenue and Forecast Analysis - by Product
  - 11.4.2.2 Middle East and Africa: ECG Devices Market - Revenue and Forecast Analysis - by Lead Type
  - 11.4.2.3 Middle East and Africa: ECG Devices Market - Revenue and Forecast Analysis - by Technology
  - 11.4.2.4 Middle East and Africa: ECG Devices Market - Revenue and Forecast Analysis - by End User
- 11.4.3 Middle East and Africa: ECG Devices Market - Revenue and Forecast Analysis - by Country
  - 11.4.3.1 Saudi Arabia: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.3.1.1 Saudi Arabia: ECG Devices Market Breakdown, by Product
    - 11.4.3.1.2 Saudi Arabia: ECG Devices Market Breakdown, by Lead Type
    - 11.4.3.1.3 Saudi Arabia: ECG Devices Market Breakdown, by Technology
    - 11.4.3.1.4 Saudi Arabia: ECG Devices Market Breakdown, by End User
  - 11.4.3.2 South Africa: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.3.2.1 South Africa: ECG Devices Market Breakdown, by Product
    - 11.4.3.2.2 South Africa: ECG Devices Market Breakdown, by Lead Type
    - 11.4.3.2.3 South Africa: ECG Devices Market Breakdown, by Technology
    - 11.4.3.2.4 South Africa: ECG Devices Market Breakdown, by End User
  - 11.4.3.3 United Arab Emirates: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.3.3.1 United Arab Emirates: ECG Devices Market Breakdown, by Product
    - 11.4.3.3.2 United Arab Emirates: ECG Devices Market Breakdown, by Lead Type
    - 11.4.3.3.3 United Arab Emirates: ECG Devices Market Breakdown, by Technology
    - 11.4.3.3.4 United Arab Emirates: ECG Devices Market Breakdown, by End User
  - 11.4.3.4 Rest of Middle East and Africa: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.3.4.1 Rest of Middle East and Africa: ECG Devices Market Breakdown, by Product
    - 11.4.3.4.2 Rest of Middle East and Africa: ECG Devices Market Breakdown, by Lead Type
    - 11.4.3.4.3 Rest of Middle East and Africa: ECG Devices Market Breakdown, by Technology
    - 11.4.3.4.4 Rest of Middle East and Africa: ECG Devices Market Breakdown, by End User
11.5 South and Central America
- 11.5.1 South and Central America ECG Devices Market Overview
- 11.5.2 South and Central America: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
  - 11.5.2.1 South and Central America: ECG Devices Market - Revenue and Forecast Analysis - by Product
  - 11.5.2.2 South and Central America: ECG Devices Market - Revenue and Forecast Analysis - by Lead Type
  - 11.5.2.3 South and Central America: ECG Devices Market - Revenue and Forecast Analysis - by Technology
  - 11.5.2.4 South and Central America: ECG Devices Market - Revenue and Forecast Analysis - by End User
- 11.5.3 South and Central America: ECG Devices Market - Revenue and Forecast Analysis - by Country
  - 11.5.3.1 Brazil: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.5.3.1.1 Brazil: ECG Devices Market Breakdown, by Product
    - 11.5.3.1.2 Brazil: ECG Devices Market Breakdown, by Lead Type
    - 11.5.3.1.3 Brazil: ECG Devices Market Breakdown, by Technology
    - 11.5.3.1.4 Brazil: ECG Devices Market Breakdown, by End User
  - 11.5.3.2 Argentina: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.5.3.2.1 Argentina: ECG Devices Market Breakdown, by Product
    - 11.5.3.2.2 Argentina: ECG Devices Market Breakdown, by Lead Type
    - 11.5.3.2.3 Argentina: ECG Devices Market Breakdown, by Technology
    - 11.5.3.2.4 Argentina: ECG Devices Market Breakdown, by End User
  - 11.5.3.3 Rest of South and Central America: ECG Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.5.3.3.1 Rest of South and Central America: ECG Devices Market Breakdown, by Product
    - 11.5.3.3.2 Rest of South and Central America: ECG Devices Market Breakdown, by Lead Type
    - 11.5.3.3.3 Rest of South and Central America: ECG Devices Market Breakdown, by Technology
    - 11.5.3.3.4 Rest of South and Central America: ECG Devices Market Breakdown, by End User

12. ECG Devices Market - Industry Landscape

12.1 Overview
12.2 Growth Strategies in the ECG Devices Market
12.3 Organic Growth Strategies
- 12.3.1 Overview
12.4 Inorganic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 GE HealthCare Technologies Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Spacelabs Healthcare
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Nihon Kohden Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Schiller AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Hill-Rom Holdings Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 BPL Medical Technologies Pvt Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Koninklijke Philips NV
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 AliveCor, Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 FUKUDA DENSHI
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 EB Neuro S.P.A
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Shenzhen Mindray Bio-Medical Electronics Co Ltd
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 Viatom Technology Co., Ltd.
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
13.13 CompuMed Inc.
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
13.14 Norav Medical
- 13.14.1 Key Facts
- 13.14.2 Business Description
- 13.14.3 Products and Services
- 13.14.4 Financial Overview
- 13.14.5 SWOT Analysis
- 13.14.6 Key Developments
13.15 custo med GmbH
- 13.15.1 Key Facts
- 13.15.2 Business Description
- 13.15.3 Products and Services
- 13.15.4 Financial Overview
- 13.15.5 SWOT Analysis
- 13.15.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.

US $ 4,450

￦ 6,438,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,450

￦ 9,332,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,450

￦ 12,226,000

※ 부가세 별도

세계의 ECG 장치 시장 규모와 예측(2021-2031년) - 지역별 점유율, 동향, 성장 기회 분석 보고서 : 제품별, 리드 유형별, 기술별, 최종 사용자별, 지역별

ECG Devices Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Lead Type, Technology, End User, and Geography

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 ECG 장치 시장 상황

제5장 ECG 장치 시장 - 주요 시장 역학

제6장 ECG 장치 시장 - 세계 시장 분석

제7장 ECG 장치 시장 분석 - 제품별

제8장 ECG 장치 시장 분석 - 리드 유형별

제9장 ECG 장치 시장 분석 - 기술별

제10장 ECG 장치 시장 분석 - 최종 사용자별

제11장 ECG 장치 시장 - 지역 분석

제12장 ECG 장치 시장 - 업계 상황

제13장 기업 프로파일